Met Life Investment Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$144.95 - $152.29 $142,775 - $150,005	985 Added 3.05%	33,319 $5.04 Million
Q3 2022 Jun 14, 2023	BUY	$144.95 - $152.29 $4.83 Million - $5.07 Million	33,319 New	33,319 $5.04 Billion
Q2 2022 May 10, 2024	BUY	$83.14 - $145.99 $207,434 - $364,245	2,495 Added 8.36%	32,334 $4.71 Million
Q2 2022 Jun 20, 2023	BUY	$83.14 - $145.99 $2.69 Million - $4.72 Million	32,334 New	32,334 $4.71 Billion
Q1 2022 May 10, 2024	BUY	$110.08 - $142.92 $3.28 Million - $4.26 Million	29,839 New	29,839 $3.54 Million
Q1 2022 Jun 20, 2023	BUY	$110.08 - $142.92 $3.28 Million - $4.26 Million	29,839 New	29,839 $3.54 Billion
Q4 2021 Jun 21, 2023	BUY	$99.73 - $148.48 $1.92 Million - $2.86 Million	19,281 New	19,281 $2.66 Billion
Q3 2021 Jun 21, 2023	BUY	$98.85 - $138.91 $1.91 Million - $2.68 Million	19,281 New	19,281 $2.68 Billion
Q2 2021 May 17, 2024	BUY	$65.78 - $105.02 $70,055 - $111,846	1,065 Added 5.85%	19,281 $1.87 Million
Q1 2021 May 17, 2024	BUY	$64.07 - $91.75 $1.17 Million - $1.67 Million	18,216 New	18,216 $1.25 Million
Q1 2021 Jun 26, 2023	BUY	$64.07 - $91.75 $1.17 Million - $1.67 Million	18,216 New	18,216 $1.25 Billion
Q4 2020 May 24, 2024	SELL	$65.07 - $98.24 $73,203 - $110,520	-1,125 Reduced 5.4%	19,691 $1.69 Million
Q4 2020 Jun 22, 2023	BUY	$65.07 - $98.24 $1.28 Million - $1.93 Million	19,691 New	19,691 $1.69 Billion
Q3 2020 Jun 26, 2023	BUY	$59.04 - $77.95 $1.23 Million - $1.62 Million	20,816 New	20,816 $1.35 Billion
Q2 2020 May 24, 2024	BUY	$29.01 - $74.23 $603,872 - $1.55 Million	20,816 New	20,816 $1.52 Billion
Q2 2020 Jun 26, 2023	BUY	$29.01 - $74.23 $603,872 - $1.55 Million	20,816 New	20,816 $1.52 Billion
Q1 2020 Jul 12, 2023	BUY	$27.51 - $57.29 $506,431 - $1.05 Million	18,409 New	18,409 $626 Million
Q4 2019 Jul 12, 2023	BUY	$40.86 - $57.65 $708,880 - $1 Million	17,349 New	17,349 $944 Million
Q3 2019 Jul 12, 2023	BUY	$37.38 - $49.47 $648,505 - $858,255	17,349 New	17,349 $724 Million
Q2 2019 Jul 12, 2023	BUY	$39.79 - $67.01 $555,786 - $935,995	13,968 New	13,968 $612 Million
Q1 2019 Jul 13, 2023	BUY	$34.52 - $53.29 $482,175 - $744,354	13,968 New	13,968 $719 Million
Q4 2018 Jul 13, 2023	BUY	$29.75 - $42.9 $361,968 - $521,964	12,167 New	12,167 $450 Million
Q3 2018 Jul 13, 2023	BUY	$32.79 - $43.0 $398,955 - $523,181	12,167 New	12,167 $457 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account